Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains-Reference-Cited by-同舟云学术

Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains

Published:2015-05-21 Issue:7 Volume:21 Page:585-590
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Chen Han-Sen¹²,Chen Xing-Miao¹²,Feng Jing-Han¹²,Liu Ke-Jian³,Qi Su-Hua⁴,Shen Jian-Gang¹²

Affiliation:

1. School of Chinese Medicine; The University of Hong Kong; Hong Kong China

2. The University of Hong Kong-Shenzhen Institute of Research and Innovation (HKU-SIRI); Shenzhen China

3. Department of Pharmaceutical Sciences; College of Pharmacy; University of New Mexico; Albuquerque NM USA

4. Research Center for Biochemistry and Molecular Biology and Provincial Key Laboratory of Brain Disease Bioinformation; Xuzhou Medical College; Xuzhou China

Funder

National Natural Science Foundation of China

Hong Kong General Research Fund

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12406/fullpdf

Reference44 articles.

1. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials;Emberson;Lancet,2014

2. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis;Lansberg;Stroke,2009

3. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association;Jauch;Stroke,2013

4. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel;Xu;CNS Neurosci Ther,2013

5. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke;Clark;JAMA,1999

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Oxidative Stress Markers in Patients with Ischemic Stroke;Biomolecules;2024-09-06

2. Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in cerebral ischemia–reperfusion injury;Journal of Neuroinflammation;2024-03-21

3. Exosome-like nanovesicles derived from Momordica charantia ameliorate delayed t-PA thrombolysis-induced hemorrhagic transformation by inhibiting the ONOO−/HMGB1/MMP-9 pathway;Journal of Functional Foods;2024-03

4. YTHDF2-regulated matrilin-3 mitigates post-reperfusion hemorrhagic transformation in ischemic stroke via the PI3K/AKT pathway;Journal of Neuropathology & Experimental Neurology;2024-01-16

5. Knockdown of Smox protects the integrity of the blood-brain barrier through antioxidant effect and Nrf2 pathway activation in stroke;International Immunopharmacology;2024-01